Study2018

Effect of olive oil phenolic compounds on osteoblast differentiation

Melguizo-Rodríguez L, Manzano-Moreno FJ, De Luna-Bertos E, Rivas A, Ramos-Torrecillas J, Ruiz C, García-Martínez O

European journal of clinical investigation · 18 citations

Review labels

Mechanisms only

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
In vitro/mechanistic study (classified by our AI screen)
Studied in
Cells or lab samples
Main outcome
Mechanisms only

Who paid for it

Funding
Independent funding
University or hospital
Universidad de Granada
Government
Junta de Andalucía
University or hospital
Department of Nursing (University of Granada)
Government
Spanish Ministry of Education
Government
BIO277 (Junta de Andalucía)
Grants
Universidad de Granada (BIO277); Junta de Andalucía (BIO277)

Based on 5 listed funder(s).

Publication

Published
2018-02-02 · Eur J Clin Invest · vol. 48 · issue 4
Publisher
Wiley
Cited
29 citations · more than 81% of similar papers · 1.4× the field average
References
30 works
Access
Open access (repository copy) · OTHER-OA
Research areas
Bone Metabolism and Diseases · Edible Oils Quality and Analysis · Biological Research and Disease Studies
Keywords
Alkaline phosphatase, Osteoblast, Apigenin, Chemistry, Luteolin, Flow cytometry, In vitro, Caffeic acid, In vivo, Biochemistry, Flavonoid, Molecular biology, Biology, Antioxidant, Enzyme, Biotechnology
MeSH
cell line, osteoblasts, humans, propionates, caffeic acids, coumaric acids, phenols, apigenin, luteolin, alkaline phosphatase, antigens, cd, flow cytometry, cell differentiation, dose-response relationship, drug, olive oil

7 authors

From ES

  • Lucía Melguizo‐RodríguezUniversidad de Granada; Instituto de Investigación Biosanitaria de Granada
  • Francisco Javier Manzano‐MorenoUniversidad de Granada; Instituto de Investigación Biosanitaria de Granada
  • Elvira De Luna‐BertosUniversidad de Granada; Instituto de Investigación Biosanitaria de Granada
  • Ana RivasUniversidad de Granada; Instituto de Investigación Biosanitaria de Granada
  • Javier Ramos‐Torrecillas · correspondingUniversidad de Granada; Instituto de Investigación Biosanitaria de Granada
  • Concepción RuízUniversidad de Granada; Instituto de Investigación Biosanitaria de Granada

Abstract

Background

Osteoporosis is a skeletal disorder characterized by compromised bone strength that predisposes individuals to an increased risk of fracture. Previous in vivo and in vitro studies have reported that phenolic compounds present in extra virgin olive oil have a beneficial effect on osteoblasts in terms of increase cell proliferation. The aim of this study was to determine whether phenolic compounds present in olive oil could modify the expression of cell differentiation markers on osteoblasts.

Study design

An in vitro experimental design was performed using MG-63 osteoblasts cell line.

Methods

MG63 cells were exposed to different doses of luteolin, apigenin, or p-coumaric, caffeic or ferulic acid. Alkaline phosphatase (ALP) was evaluated by spectrophotometry and antigen expression (cluster of differentiation [CD] 54, CD80, CD86 and HLA-DR) by flow cytometry.

Results

At 24 hour, treated groups showed an increased ALP and modulated antigen profile, with respect to the nontreated group.

Conclusion

These results demonstrate that the phenolic compounds studied induce cell maturation in vitro, increasing ALP synthesis and reducing the expression of antigens involved in immune functions of the osteoblast which would improve bone density.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.